Investors in Insulet Corp (Symbol: PODD) saw new options become available this week, for the November 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PODD ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Insulet (PODD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...

Insulet (PODD) is back on investors’ radar after recent trading pressure, with the share price showing declines over the past ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Insulet delivers strong fundamentals, with robust revenue growth, high margins, and impressive returns on capital, driven by Omnipod's success. PODD's Q3 results were strong, featuring record revenues ...

6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...